Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket

Gainers

• Fast Radius, Inc. FSRD shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11.
• Digital Turbine, Inc. APPS rose 21.4% to $13.07 in pre-market trading after the company reported mixed Q2 results.
• Magnite, Inc. MGNI rose 17% to $6.76 in pre-market trading after the company reported better-than-expected Q3 results.
• Canoo Inc. GOEV rose 16.2% to $1.36 in pre-market trading after the company reported Q3 results and announced plans to acquire vehicle manufacturing facility in Oklahoma City.
• Heliogen, Inc. HLGN shares rose 15% to $1.15 in pre-market trading after dipping 25% on Wednesday. Heliogen recently posted a Q3 loss of $0.14 per share.
• Virax Biolabs Group Limited VRAX rose 13.9% to $1.56 in pre-market trading. Virax Biolabs Group recently announced closing of $3.8 million private placement.
• Coupang, Inc.. CPNG rose 11.3% to $18.13 in pre-market trading after the company reported better-than-expected Q3 EPS results.
• OmniAb, Inc. OABI rose 10.8% to $3.06 in pre-market trading. OmniAb President and CEO Matthew Foehr bought a total of 100,000 shares at an average price of $2.76.
• AST SpaceMobile, Inc. ASTS rose 10.3% to $7.31 in pre-market trading after declining around 9% on Wednesday.
• ADMA Biologics, Inc. ADMA rose 9.3% to $2.70 in pre-market trading after the company reported better-than-expected Q3 results and raised FY22 guidance.
• CleanSpark, Inc. CLSK rose 8.6% to $2.70 in pre-market trading after dropping 15% on Wednesday.
• BARK, Inc. BARK rose 8% to $1.77 in pre-market trading after the company reported better-than-expected Q2 results.
• AbCellera Biologics Inc. ABCL rose 7.6% to $12.71 in pre-market trading after the company reported better-than-expected Q3 results.
• Rivian Automotive, Inc. RIVN rose 7.2% to $30.10 in pre-market trading after the company reported better-than-expected Q3 EPS results.
• Huadi International Group Co., Ltd. HUDI shares rose 7.1% to $9.26 in pre-market trading. Huadi International Group reported closing of $25 million registered direct offering.
• Trip.com Group Limited TCOM rose 5.2% to $26.29 in pre-market trading after dropping 8% on Wednesday.

Don’t forget to check out our premarket coverage here .

Losers

• Cano Health, Inc. CANO shares fell 31.7% to $2.28 in pre-market trading after the company reported worse-than-expected Q3 EPS and sales results. Raymond James downgraded Cano Health from Outperform to Market Perform.
• Vacasa, Inc. VCSA fell 26.5% to $2.63 in pre-market trading after the company reported worse-than-expected Q3 EPS results.
• Edgio, Inc. EGIO shares fell 19.9% to $1.73 in pre-market trading after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates.
• Organogenesis Holdings Inc. ORGO shares fell 17.5% to $2.55 in pre-market trading after the company reported worse-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance below analyst estimates.
• Desktop Metal, Inc. DM fell 13.7% to $1.89 in pre-market trading after the company reported worse-than-expected Q3 results.
• Bumble Inc. BMBL fell 13.2% to $18.16 in pre-market trading after the company reported worse-than-expected Q3 sales and issued weak Q4 guidance.
• NeuroBo Pharmaceuticals, Inc. NRBO fell 11.1% to $1.44 in pre-market trading after jumping around 30% on Wednesday.
• Digital World Acquisition Corp. DWAC fell 10% to $20.30 in pre-market trading after dropping around 20% on Wednesday.
• Avenue Therapeutics, Inc. ATXI fell 9.4% to $1.70 in pre-market trading after gaining 13% on Wednesday.
• GeoVax Labs, Inc. GOVX fell 8.9% to $0.7062 in pre-market trading after posting a wider-than-expected Q3 loss.
• SenesTech, Inc. SNES shares fell 8.2% to $0.1409 in pre-market trading. SenesTech is expected to report Q3 financial results on Monday, November 14, 2022.
• B&G Foods, Inc. BGS shares fell 8% to $13.48 in pre-market trading after the company reported worse-than-expected Q3 sales results and lowered its FY22 EPS guidance below analyst estimates.
• Meta Materials Inc. MMAT shares fell 7.2% to $1.29 in pre-market trading after the company reported downbeat Q3 results.